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Summary: The major fraction of deoxyribonuclease activity from human urinary protein was purified 40-fold in
about 14% yield. The enzyme shows an isoelectric point at pH 4.2 and has a molecular weight of 33,600 ± 3,000.
Optimum activity was shown at pH 6.8 in the presence of 12.5 mmol/1 Mg2* plus 1 mmol/1 Ca2+.
The enzymic reaction is inhibited by high ionic strength (> 300 mmol/1 Na+). The purified enzyme readily hydro-
lyzes native DNA to oligodeoxyribonucleotides with an average chain length of 5.3 ± 0.2 after exhaustive digestion.
Therefore, this endonuclease may be designated as neutral deoxyribonuclease (deoxyribonucleate oligonucleotido-
hydrolase, EC 3.1.4.5).
Die Desoxyribonuclease mit der höchsten Enzymaktivität aus menschlichem Harn: Reinigung und Eigenschaf ten
Zusammenfassung: Aus menschlichem Harn wurde die Hauptfraktion der Desoxyribonucleaseaktivität 40-fach an-
gereichert in einer Ausbeute von 14%. Das Enzym hat einen I. P. von 4,2 und ein Mr von 33.600 ± 3.000. Das Akti-
vitätsoptimum liegt bei pH 6,8 unter Zusatz von 12,5 mmol/1 Mg2+ und l mmol/1 Ca2+.
Native DNA wird bevorzugt abgebaut und als Endprodukte fallen Oligonucleotide mit einer mittleren Kettenlänge
von 5,3 ± 0,2 an. Das Enzym wurde als Endonuclease eingeordnet (EC 3.1.4.5).
Introduction
Deoxyribonucleases (DNases) and other types of nücleo-
lytic enzymes are widely distributed in nature.
Several laboratories have described DNäse activities from
human tissues, e. g. placenta (1), pancreas (2), epidermis
(3,4) and from cultured cells, e. g. HeLa cells (5-8) and
fibroblasts (9,10).
Furthermore, DNases were found in human body fluids,
such as serum (11) urine (12), seminal plasma (13,14),
and liquor cerebrpspinalis (15, 16).
Electrophoretic patterns of DNase activities from hunian
body fluids have been published for serum (17), urine
(18), seminal plasma (19) and liquor cerebrpspinalis (20).
Based on the electrophoretic data, the present study re-
ports the isolation of the major fraction of DNase acti-
vity from human urine.
Materials and Methods
DNA from herring sperm ) was prepared according to the pro-
cedure of Zahn et al. (21). Yeast RNA was purchased from
C. F. Boehringer & Co (Mannheim/FRG).
Sephadex G-10, O75 and G-100, dextran blue 2000, DEAE
Sephadex A-25 and SE Sephadex C-50 were products of Pharma-
cia (Uppsala/Sweden). The proteins used as standards in the esti-
mation of the molecular weight of human urinary DNase were
obtained as a protein calibration kit from C. F. Boehringer (Mann-
heim/FRG).
Bovine serum albumin for DNase assay was obtained from Serva
(Heidelberg/FRG), p-nitrophenyl phosphate as the disodium salt
was purchased from E. Merk (Darmstadt/FRG), p-nitrophenyl
thymidine 5'-phosphate and its 3'-isomer as the sodium or ammo-
nium salt were purchased from Calbiochem (Los Angeles/Ca.
90054/USA). Chemicals required for gel electrophoresis were
from E. Merck (Darmstadt/FRG), Ampholine, pH 3.5-10, was
a product of LKB Produkter AB (Stockholm/Sweden).
*) Herring sperm DNA was a gift of H. Mack (Illertissen/Bay./
FRG).
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The enzymes used were from C. F. Boehringer (Mannheim/FRG),
alkaline phosphatase from calf intestine, snake venom phospho-
diesterase from Crotalus terr. terr., and spleen phosphodiesterase.
DNase assay
a) Enzyme activity was generally estimated by the hyperchromi-
city method ofKunitz (22). 1 mU = increase of 0.001 A260·
b) DNase activity embedded in polyacrylamide gels was deter-
mined by the methyl-green DNA decolorization test (11, 23).
c) Disc electrophoresis of DNase was performed as described by
Ornstein (24) and Davis (25). After the electrophoretic run the
gels were developed according to Boyd & Mitchell (26).
Molecular weight determination
Two different methods were applied in order to determine the
molecular weight of the DNase: sucrose gradient centrifugation
(27) and gel filtration (28).
Estimation of the isoelectric point of the DNase
The electrofocusing procedure was performed according to
Catsimpoolas (29).
DNase Digestion
The mode of nucleolytic attack was investigated by gel filtration
of the digests on Sephadex G-100 according to Birnboim (30).
Furthermore, the hydrolysates were segregated by length accor-
ding to the procedure ofRushizky et al. (31).
Phosphodiesterase Digestion
The reaction mixture (total volume, 1 ml) contained 100 μΐ of
enzyme (diluted 1:600) and a final substrate concentration of
0.15 mmol/1 DNA phosphorus in 50 mmol/1 Tris/HCl buffer,
pH 8.5. Conditions for incubation were room temperature, over-
night. Estimation of total phosphorus according to 1. c. (32).
Release of phosphatase-sensitive phosphorus
300-μΙ samples were supplemented with 20 μΐ of 1 mol/1 Tris/
HC1 buffer, pH 8.0, and 10 μΐ of calf intenstinal phosphatase.
Incubation was carried out at 37 °C for 30 min.
Assays for contaminant enzymes
The activities of ribonuclease, phosphodiesterase and phospha-
tase were measured as described earlier (33).
Estimation of protein
Protein concentration was measured according to Lowry et al.
(34).
Results
Purification of the enzyme
All preparations were performed at 4 °C.
Step I: Preparation of the raw concentrate
30 liters of freshly collected samples of urine were made
0.2 g/1 with respect to sodium azide, supplemented with
EDTA to a final concentration of 10 mmol/1, adjusted to
pH 7.0, and diluted with an equal volume of distilled
water. 10 ml of DEAE Sephadex A-25 (equilibrated with
50 mmol/1 Tris/HCl buffer, pH 7.0, containing 10 mmol/1
EDTA) were added and the slurry was stirred for 12 hours.
The batchwise processing with DEAE Sephadex was repea-
ted two times with newly added DEAE Sephadex. The
collected sediments were eluted three times with 60 ml
of 300 mmol/1 NaCl containing 3 mmol/1 CaCl2. The
extracts (total volume, 180 ml) were concentrated against
polyethylene gjycol. This step I preparation was allowed
to stand in the deep-freeze (-20 °C). When thawed after
6 weeks, the samples showed a 12% loss of enzymic acti-
vity.
Step II: Gel filtration on Sephadex G-10
The gel was equilibrated with 5 mmol/1 sodium acetate
buffer, pH 6.85. 6 ml of the crude extract (Step I) were
applied to the column (3.6 X 23 cm) which then was
washed with 190 ml of the same buffer at a flow rate of
120 ml per hour. The active fractions, made 100 g/1 with
respect to sorbit l (Karion F), represent Step II.
Step III: Chromatography on SE Sephadex C-25
The gel was equilibrated with 5 mmol/1 sodium acetate
buffer, pH 4.7 containing 100 g/1 of sorbitol.
The Step II solution was adjusted to pH 4.7 and placed
on the column (1.5 X 12 cm), and the fractions con-
taining the major enzymic activity appeared in the flow-
through. These fractions were supplemented with
5 mmol/1 CaCl2. After a 3-hour period the solution was
brought to final concentration of 50 mmol/1 Tris/HCl,
pH 6.5, and permitted to stand overnight (Step III frac-
tion).
Step IV: First chromatography on DEAE Sephadex
A-25
DEAE Sephadex was equilibrated with 50 mmol/1 Tris/
HC1 buffer, pH 7.0, containing 50 mmol/1 EDTA, pH 7.0,
and finally equilibrated with 50 mmol/1 Tris/HCl, pH 7.0,
containing 10 g/1 sorbitol. The Step HI solution was
supplemented with 10 mmol/1 EDTA, adjusted to pH 7.0,
and applied to a column (1.5 X 10 cm) of DEAE Sepha-
dex A-25. After loading, the column was washed with
the final equilibrating buffer containing 75 mmol/1 NaCl.
The enzyme activity was eluted at a reduced flow rate
of 20 ml/h with the processing buffer, after addition of
NaCl and CaCl2 to final concentrations of 150 mmol/1
and 3 mmol/1, respectively. The fractions containing en-
zyme activity were pooled, stabilized by adding DNA and
MgCl2 to final concentrations of 1 mg/1 and 5 mmol/1
respecitvely, and designated as Step IV.
Step V: Lyophilization
the Step IV fraction was dialysed for 24 hours against
two changes of distilled water (6 liter) and subsequently
freeze-dried.
Step VI: Filtration on Sephadex G- 75
The Step V lyopMlisate was redissolved in 50 mmol/1
ammonium formate buffer, pH 7.0, and chromatogra-
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phed on a Sephadex G-75 column (5 X 20 cm). Fractions
containing enzymic activity were designated as Step VI.
Step VII: Second chromatography on DEAE Sephadex
A-25
The Step VI solution was applied to a DEAE Sephadex
column (0.8 X 6 cm) equilibrated with 50 mrnol/1 ammo-
nium formate buffer, pH 7.O. Elution was carried out
with a linear gradient (total volume, 140 ml) of ammoni-
um formate from 50 to 500 mmol/1. The eluted samples
of enzymic activity were stored in a deep freeze (Step
VII fraction).
Step VII fraction was used for the experiments described.
The course of a typical fractionation (of a four-fold
assay) is detailed in table 1.
Properties of the enzyme
After electrophoresis, the stage VII preparation produced
only a single sharp band of DNase activity (see fig. 1, b).
By incubation of the purified DNase solution over a 24-
hour period evidence was obtained that the DNase prepa-
ration is devoid of phosphomonoesterase and phospho-
diesterase activities. Traces of ribonuclease activity both
Φ
Electrophoresis Electrophoresis
Fig. 1. Densitometer tracings of methyl-green DNA-containing polyacrylamide gels after electrophoresis, incubation and staining of
the separated urinary DNase activity at different stages of the purification procedure. The gel contained 0.2 mg methyl-green
DNA per ml of 150 g/1 polyacrylamide running gel at pH 8.7. For experimental conditions, see Methods.
a) Scanning of DNase activity from native urine;
b) Tracing of DNase pheretogram from Step VII solution.
The direction of electrophoresis is indicated by the arrow on the abscissa; the ordinate shows transmittance.
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Fig. 2. The effect of pH on the hyperchromicity at 260 nm induced by the urinary DNase.
Enzyme activity against native DNA was measured in the standard assay system except that the pH varied with different
buffers added. The buffers used were sodium citrate for pH values ranging from 3-4, sodium acetate for pH values ranging from
4-6, Tris/HCl for pH values ranging from 7-8, and sodium borate for pH values ranging from 9-10 with a final concentration
of 50 mmol/1, respectively.
(left) pH optimum with a constant Na* concentration of 50 rhmql/1 and varying Mg2* concentration, -Δ- = 1 mmol/1;
-o- = 3 mmol/1; -·- = 10 mmol/ί; (right) pH optimum with 3 mmol/1 Mg2* and variable Na* concentrations; -o-,
50 mmol/1; -·-, 100 mmol/l; -A-, 300 mmol/1.
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Tab. 1. Purification procedure
Step Volume Total Total Specific
(ml) protein activity activity
(mg) (mUnits) (mUnits/mg)
I Crude concen- 22.5
träte
IISephadexG-10 440
gel filtration
III SE Sephadex 468
chromatography
IV First DEAE 433
Sephadex
chromatography
V Lyophilisate 2.8
VI Sephadex G-75 95
gel filtration
VII Second DEAE 61
Sephadex
chromatography
*)
68
70
41
0.6
0.2
136
135
49
34
37
31
18
2.0
0.7
0.8
54.2
83.6
*) correct protein estimation could not be carried out in the
presence of the accompanying material.
at pH 5.8 and pH 8.0 were detectable. The purified DNase
activity was remarkably stable against heat inactivation at
pH 7 up to 50 °C. The molecular weight of the urinary
DNase was estimated to 33,600 (table 2).
Applying the electrofocusing method (29) the isoelectric
point obtained is at pH 4.2.
The DNase exhibits maximum activity at pH 6.8 (fig. 2).
At a final DNA concentration of 100 Mg per ml, the opti-
mum Mg2+ concentration is 3.3 ± 0.1 mmol/1 at pH 7.
The addition of 1 mmol/1 Ca2+ shifts the optimum Mg2+
concentration to 12.5 mmol/1. In order to determine
whether the enzyme functions in an endo- or exonucleo-
lytic fashion, the enzymic digestion of DNA was
followed as described by Birnboim (30). Based on the
elution patterns presented in figure 3 the DNase should
be classified as an endonuclease.
After exhaustive digestion the hydrolyzate of DNA was
chromatographed on DEAE-Sephadex. The elution pat-
tern as presented in figure 4 shows discrete peaks up to
pentamers and a non-resolved portion of large-sized oli-
gomers.
Tab. 2. Comparison of average molecular weight of deoxyribonu-
clease from human urine as determined by two methods
Evaluating the time course of DNase attack the average
chain length of the fragments was decreasing from 28 ±
4 at 30 min to 5.3 ± 0.2 at 24 h.
40
30
120
10
10 20 ~ 30
Fraction number
50
40
30
120
10 20 30
Fraction number
40 50
Methods and standard proteins Molecular Average
weight
Sucrose density centrifugation . . . .
cytochrome c
chymotrypsinogen . . . .
ovalbumin
bovine serum albumin . .
Sephadex gel filtration*)
Average of the two methods . . . .
28 600
29,250
36 000
36,450
32,580
34 530
33,600
*) for proteins used as standards, see Methods
Fig. 3. Chromatography on Sephadex G-100 of native DNA at
different stages during its digestion with DNase. The
column (1.5 X 23.5 cm) was packed with Sephadex
G-100 and 1 ml Sephadex G-1Ö was layered onto its
surface. Equilibration was performed with SO mmql/1
ammonium formate buffer, pH 7.O. incubation mixture
(total volume, 10 ml) contained 2 mg of native DNA in
50 mmol/1 Tris/HCl buffer, pH 7.0, 25 mmol/1 Mg2* and
1 mmol/1 Ca2*, and 1 ml of enzyme (Step VII fraction).
The elution patterns shown in the upper graphs were of
1 ml aliquots of the reaction mixture when incubated at
37 °C for (a)-, 5 min, (b) , 20 min, (c) -H-+ 30 min,
(d) ..., 60 min* (e) x-x, 90 min, (f) -^,180 min, and
(g) --·-, 240 min. Incubation was stopped by •making
0 the sample 3 mo 1/1 with respect to NaCi. Elution was
performed with the equilibrating buffer. In the löwer
graph the elution pattern of a mixture of 400 Mg of
native DNA (1) and 400 Mg of dCMP plus 250 Mg of
dGMP (2) is shown.
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Fig. 4. Elution profile of hydrolysate of DNA extensively
digested with human DNase, step VII fraction. The
reaction mixture (total volume, 10 ml) containing
10 mmol/1 Tris/HCl buffer, pH 7.0, 200 Mg/ml herring
sperm DNA, 12.5 mmol/1 Mg2*, and 1 mmol/1 Ca2* was
incubated for 7 h at 37°C, diluted with distilled water
to a final volume of 30 ml and layered onto a DEAE
Sephadex A-25 column (0.9 X 29 cm) which had been
equilibrated with 10 mmol/1 Tris/HCl buffer, pH 7.8,
and 7 mol/1 urea. After washing with 30 ml of the
processing buffer, elution was performed with a linear
NaCl gradient from 0 to 0.5 mol/1 NaCl in the same
buffer. The total volume of the gradient was 460 ml and
5-ml fractions were collected. Aliquots (0.2 ml) were
used both for the estimation of total phosphorus and
the-phosphorus sensitive to alkaline phosphatase from
calf intestine; for details see Methods. The remainder was
measured at 271 nm.
The Roman numbers positioned directly above each peak
indicate the respective chain length.
Ordinate: (left scale) Absorbance at 271 nm, ; (right
scale) NaCl gradient mmol/1, ;
In order to obtain information on the position of the ter-
minal phosphate in oligomers from DNase cleavage the
hydrolyzate was subsequently digested by means of snake
venom and spleen phosphodiesterase, respectively.
Figure 5 illustrates the Chromatographie patterns on
Sephadex G-100 of digests exhaustively cleaved by DNase
(1) and subsequently treated with additional (2) spleen
phosphodiesterase or (3) snake venom phosphodiesterase.
Evidence could be obtained that the peak of material ab-
sorbing at 260 is shifted to regions of lower molecular
weight by subsequent treatment of DNase digest with
both spleen arid venom ex nticlease. But, in the case of
venom phosphodiesterase the migration to values of
lower molecular weights is faster than in the case of the
spleen enzyme. Therefore, it may be concluded that the
fragments of DNase digestion carry phosphate at the 5'
termini.
Discussion
The main problem of the purification procedure was the
separation of two DNase activities which apparently are
very similar. In the tracings of the electrpphoretic runs
ΟΛ
0.3
S
«χ
0.2
0.1
30
Fraction number
50
Fig. 5. Chromatography on Sephadex G-100 of cleavage
fragments of a combined DNase/phosphodiesterase assay.
10 ml of a DNase incubation mixture were treated as
described in Methods except that the incubation period
was 7 h. Afterwards the reaction mixture was divided
into three 3-ml portions. -—, digest of DNase, without
further treatment as control; , digest of DNase, plus
10 μΐ snake venom phosphodiesterase, after adjusting to
pH 8.0, running over night, room temperature; -ο—,
DNase digest plus 10 μΐ spleen phosphodiesterase was
brought to pH 8.0 and incubation was carried out over-
night at room temperature.
For gel filtration a Sephadex G-100 column (1.5 X
23.5 cm) was equilibrated with 50 mmol/1 ammonium
formate buffer, pH 7.0. 1 ml aliquots of the assays
specified above were applied separately to the column.
the concomitant DNase component stands out clearly as
a shoulder of the main band distinctly recorded in figure
1, a. We succeeded in solving this problem using SE Sepha-
dex chromatography (Step III) by which the accom-
panying component was eliminated from the main frac-
tion. Stage VII of the enzyme preparation produced only
a single peak of DNase activity when monitored on disc
electrophoresis (fig. 1, b). Different concentrations of
Tris/HCl buffer ranging from 20—50 mmol/1 had no
apparent influence on the DNase catalyzed reaction,
whereas discrete changes in reaction rate due to variations
in the concentration of Na+ can be shown, using different
buffers containing sodium as its acetate, citrate, or bo-
rate. This is important, since effects measured in Tris or
sodium-containing buffers are only comparable if the
Tris-buffered system is supplemented with Na+.
J. din. Chem. Clin. Biochem. / Vol. 16,1978 / Nci. 11
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Since a considerable effect of Na*on the rate of reaction
has been evidenced, a basic Na+ concentration of
50 mmol/1 must be maintained irrespective of the nature
of the buffer used. Na+ concentrations higher than
300 mmol/1 are strongly inhibitory.
The optimum incubation conditions established for the
assay of the enzyme are 0.3 mmol/1 DNA phosphorus,
pH 6.8, in the presence of 12.5 mmol/1 Mg2+plus 1 mmol/1
Ca2+. It is interesting to note that a similar interdepend-
ence between Ca2+ and Mg2+concentration has been de-
scribed by another laboratory for bovine pancreatic
DNase I (35-37). The human urinary DNase attacks
preferently native DNA and degrades the substrate, after
exhaustive digestion, to oligomers of an average chain
length of around 5, indicating that it acts as an endonu-
clease. Since snake venom phosphodiesterase degrades
the oligomers of the DNase digest to monodeoxynucleo-
tides faster than spleen phosphodiesterase, it may be
suggested that the oligomers are characterized by a phos-
phqrylated 5' terminus (38,39).
The DNase is devoid of phosphodiesterase and phospho-
monoesterase activities and only trace amounts of RNase
activity are detectable. The urinary DNase described in
this paper exhibits some common properties with mam-
malian pancreatic DNase I and may be classified as a neu-
tral deoxyribonuclease (deoxyribonucleate oligonucleoti-
dohydrolase, EC 3.1.4.5). Despite these similarities, it
may not be assumed that this enzyme is identical with
that of pancreatic origin.
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